Emtricitabine Related Compounds & Impurities

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with potent anti-HIV and anti-HBV activity, used as a backbone of first-line antiretroviral combinations.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Emtricitabine reference standards, pharmacopeial and non-pharmacopeial Emtricitabine impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Emtricitabine-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Emtricitabine
Emtricitabine Racemic Mixture
Emtricitabine
Emtricitabine Carboxylic Acid
Emtricitabine S-Oxide
(2S,5R) Emtricitabine Menthyl Ester
Emtricitabine 5-Fluorouracil Analog Impurity
Emtricitabine Menthyl Ester Impurity
Emtricitabine Enantiomer
Emtricitabine O-beta-D-Glucuronide Sodium Salt
Emtricitabine Tenofovir Disoproxil Dimer
Emtricitabine Tenofovir Monosoproxil Dimer
Emtricitabine Trans-Cyclic Impurity
Emtricitabine cis-Cyclic Impurity
Emtricitabine Impurity 7
(+)-Menthol
(+)-Neomenthol
2-epi-Emtricitabine
Emtricitabine Disulfide
Emtricitabine 5-Fluorouracil Analog
Emtricitabine Dimer Impurity
Emtricitabine Impurity 6
Emtricitabine Impurity 8
Emtricitabine Impurity 9
(-)-Neomenthol
Emtricitabine Isomer -2
5-Fluoro-3`-thia-2`,3`-dideoxyuridine
5-epi Emtricitabine
Emtricitabine Methyl Ester
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl(2R,5R)-5-methoxy-1,3-oxathiolane-2-carboxylate
(2R,5S)-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-1,3-oxathiolate
Emtricitabine Isopropyl Carbamate
Emtricitabine-Tenofovir Disoproxil Fumarate
Emtricitabine-Tenofovir Alafenamide Hemifumarate
Emtricitabine Uracil Impurity
Emtricitabine Impurity 24
4-amino-5-fluoro-1-[(2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
(-)-Beta-D-Dioxolane-5-fluoro Cytidine
Emtricitabine Impurity 19
Emtricitabine Impurity 18
Emtricitabine Desamino Impurity
Emtricitabine Glycosamine
(2S,5S)-Emtricitabine Carboxylic Acid
Emtricitabine Sulfoxide Isomer 1
Emtricitabine Sulfoxide Isomer 2
Emtricitabine Diastereomer (RS ISOMER )
Emtricitabine Isomer -1
Emtricitabine Glycosamine
Emtricitabine+Des-Phenol Tenofovir Alfenamide Mixed Dimer
Emtricitabine Carboxylic Acid Relative
(2S,5R)-Emtricitabine Carboxylic Acid
(2S,5S) Emtricitabine Menthyl Ester
Emtricitabine Impurity 3
Emtricitabine Resolution Mixture
Emtricitabine sulfoxide Isomer 3
Emtricitabine Impurity 1
Emtricitabine 5-Fluorouracil Analog(Rel)

Isotope Labelled Compounds

Emtricitabine-13C,15N2
Emtricitabine 15N, D2
Emtricitabine-d3,15N
Emtricitabine D3